JP2023156353A5 - - Google Patents

Download PDF

Info

Publication number
JP2023156353A5
JP2023156353A5 JP2023121818A JP2023121818A JP2023156353A5 JP 2023156353 A5 JP2023156353 A5 JP 2023156353A5 JP 2023121818 A JP2023121818 A JP 2023121818A JP 2023121818 A JP2023121818 A JP 2023121818A JP 2023156353 A5 JP2023156353 A5 JP 2023156353A5
Authority
JP
Japan
Prior art keywords
residue
isolated
amino acid
purified peptide
peptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2023121818A
Other languages
English (en)
Japanese (ja)
Other versions
JP7855180B2 (ja
JP2023156353A (ja
Filing date
Publication date
Priority claimed from PCT/AU2018/050883 external-priority patent/WO2019036753A1/en
Application filed filed Critical
Publication of JP2023156353A publication Critical patent/JP2023156353A/ja
Publication of JP2023156353A5 publication Critical patent/JP2023156353A5/ja
Application granted granted Critical
Publication of JP7855180B2 publication Critical patent/JP7855180B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2023121818A 2017-08-22 2023-07-26 終末糖化産物受容体(rage)の活性化のスクリーニングアッセイ、モジュレーター及び調節 Active JP7855180B2 (ja)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
AU2017903381A AU2017903381A0 (en) 2017-08-22 Screening Assays, Modulators and Modulation of Activation of Receptor For Advanced Glycation End-Products (RAGE)
AU2017903381 2017-08-22
AU2018902298A AU2018902298A0 (en) 2018-06-26 Screening Assays, Modulators and Modulation of Activation of Receptor for Advanced Glycation End-Products (RAGE)
AU2018902298 2018-06-26
PCT/AU2018/050883 WO2019036753A1 (en) 2017-08-22 2018-08-21 SCREENING TESTS, MODULATORS AND MODULATION OF RECEIVER ACTIVATION FOR ADVANCED GLYCATION TERMINAL PRODUCTS (RAGE)
JP2020511214A JP7865475B2 (ja) 2017-08-22 2018-08-21 終末糖化産物受容体(rage)の活性化のスクリーニングアッセイ、モジュレーター及び調節

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2020511214A Division JP7865475B2 (ja) 2017-08-22 2018-08-21 終末糖化産物受容体(rage)の活性化のスクリーニングアッセイ、モジュレーター及び調節

Publications (3)

Publication Number Publication Date
JP2023156353A JP2023156353A (ja) 2023-10-24
JP2023156353A5 true JP2023156353A5 (cg-RX-API-DMAC7.html) 2024-02-21
JP7855180B2 JP7855180B2 (ja) 2026-05-08

Family

ID=65438276

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2020511214A Active JP7865475B2 (ja) 2017-08-22 2018-08-21 終末糖化産物受容体(rage)の活性化のスクリーニングアッセイ、モジュレーター及び調節
JP2023121818A Active JP7855180B2 (ja) 2017-08-22 2023-07-26 終末糖化産物受容体(rage)の活性化のスクリーニングアッセイ、モジュレーター及び調節
JP2025227130A Pending JP2026062654A (ja) 2017-08-22 2025-12-03 終末糖化産物受容体(rage)の活性化のスクリーニングアッセイ、モジュレーター及び調節

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2020511214A Active JP7865475B2 (ja) 2017-08-22 2018-08-21 終末糖化産物受容体(rage)の活性化のスクリーニングアッセイ、モジュレーター及び調節

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025227130A Pending JP2026062654A (ja) 2017-08-22 2025-12-03 終末糖化産物受容体(rage)の活性化のスクリーニングアッセイ、モジュレーター及び調節

Country Status (7)

Country Link
US (2) US12060408B2 (cg-RX-API-DMAC7.html)
EP (1) EP3672982B1 (cg-RX-API-DMAC7.html)
JP (3) JP7865475B2 (cg-RX-API-DMAC7.html)
CN (2) CN120607606A (cg-RX-API-DMAC7.html)
AU (1) AU2018322482B2 (cg-RX-API-DMAC7.html)
CA (1) CA3109871A1 (cg-RX-API-DMAC7.html)
WO (1) WO2019036753A1 (cg-RX-API-DMAC7.html)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3109871A1 (en) * 2017-08-22 2019-02-28 Monash University Screening assays, modulators and modulation of activation of receptor for advanced glycation end-products (rage)
KR102203850B1 (ko) * 2019-04-09 2021-01-18 사회복지법인 삼성생명공익재단 신경교종의 진단 또는 예후 예측용 조성물 및 이에 관한 정보를 제공하는 방법
EP4168548A1 (en) 2020-06-22 2023-04-26 Regeneron Pharmaceuticals, Inc. Treatment of obesity with g-protein coupled receptor 75 (gpr75) inhibitors
WO2022150709A1 (en) * 2021-01-11 2022-07-14 President And Fellows Of Harvard College Compositions and methods for treating viral infection
CN113293212A (zh) * 2021-06-17 2021-08-24 深圳华因康基因科技有限公司 一种检测神经母细胞瘤复发转移基因fzd2扩增的引物探针及其应用
CN113789379B (zh) * 2021-08-30 2022-08-23 远见生物科技(上海)有限公司 一种检测前列腺癌的诊断试剂盒及其检测方法与应用
JP2023084477A (ja) * 2021-12-07 2023-06-19 花王株式会社 硫黄化合物を原因とするにおいの抑制剤の評価及び/又は選択方法
WO2023140700A1 (ko) 2022-01-24 2023-07-27 서울대학교산학협력단 장 미각 수용체 tas1r3 발현 및 활성화 억제를 통한 서구식 식이 유발 염증성 장 질환의 예방 또는 치료
WO2023164290A2 (en) * 2022-02-28 2023-08-31 Arizona Board Of Regents On Behalf Of The University Of Arizona Methods and compositions for treating cancers and other proliferative disorders
KR20230147988A (ko) * 2022-04-15 2023-10-24 아주대학교산학협력단 Rage 길항제 및 age 소거제를 포함하는 당뇨성 뇌졸중 예방 또는 치료용 약학적 조성물
WO2024044659A1 (en) * 2022-08-24 2024-02-29 Tectonic Therapeutic, Inc. Constitutively active g protein-coupled receptor compositions and methods of use thereof
CN115798616B (zh) * 2022-10-26 2026-06-19 大连大学 基于dna链置换的新型生物分子控制器的实现方法
CN118777620A (zh) * 2023-04-07 2024-10-15 浙江友宁生物医药科技有限公司 Gpr139受体激活检测方法、生理功能评价方法及应用
CN116410335B (zh) * 2023-04-24 2024-08-13 徐州医科大学 一种多肽tat-mrgprx1c及其应用
CN118755834B (zh) * 2024-07-15 2025-11-18 河北医科大学第四医院(河北省肿瘤医院) 胃癌复发预测模型
CN119901926A (zh) * 2025-03-31 2025-04-29 浙江省立同德医院(浙江省精神卫生研究院) 一种基于rage过表达和spr技术的rage靶向药物筛选方法
CN121695261B (zh) * 2026-02-11 2026-04-17 湖南启元生物科技有限公司 一种蛋白组合物及其制备方法
CN121774990A (zh) * 2026-03-05 2026-04-03 浙江省中医院、浙江中医药大学附属第一医院(浙江省东方医院) 七叶皂苷钠在制备防治糖尿病视网膜病变药物中的应用

Family Cites Families (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3773919A (en) 1969-10-23 1973-11-20 Du Pont Polylactide-drug mixtures
US5004687A (en) 1985-05-21 1991-04-02 University Of Georgia Research Foundation, Inc. Insect virus vector with broadened host range
US4868103A (en) 1986-02-19 1989-09-19 Enzo Biochem, Inc. Analyte detection by means of energy transfer
US5273876A (en) 1987-06-26 1993-12-28 Syntro Corporation Recombinant human cytomegalovirus containing foreign gene
CA2045129A1 (en) 1989-02-01 1990-08-02 Alfred I. Geller Herpes simplex virus type i expression vector
GB8923123D0 (en) 1989-10-13 1989-11-29 Connaught Lab A vaccine for human immunodeficiency virus
EP0549723A1 (en) 1990-09-21 1993-07-07 Chiron Corporation Packaging cells
ATE188740T1 (de) 1991-02-19 2000-01-15 Univ California Viruspartikel mit veraendertem wirtspektrum
GB9105383D0 (en) 1991-03-14 1991-05-01 Immunology Ltd An immunotherapeutic for cervical cancer
US6013638A (en) 1991-10-02 2000-01-11 The United States Of America As Represented By The Department Of Health And Human Services Adenovirus comprising deletions on the E1A, E1B and E3 regions for transfer of genes to the lung
EP0552108B1 (en) 1992-01-17 1999-11-10 Lakowicz, Joseph R. Energy transfer phase-modulation fluoro-immunoassay
AU3972893A (en) 1992-04-03 1993-11-08 Baylor College Of Medicine Gene therapy using the intestine
US6130074A (en) 1992-06-01 2000-10-10 American Cyanamid Company Five Giralda Farms Recombinant insect virus with reduced capacity for host-to-host transmission in the environment and methods to produce said virus
SE9201984D0 (sv) 1992-06-29 1992-06-29 Pharmacia Biosensor Ab Improvement in optical assays
JP3147514B2 (ja) 1992-07-08 2001-03-19 住友電装株式会社 電線送給装置
AU6014094A (en) 1992-12-02 1994-06-22 Baylor College Of Medicine Episomal vectors for gene therapy
AU680508B2 (en) 1993-04-06 1997-07-31 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Gibbon ape leukemia virus-based retroviral vectors
US6133028A (en) 1993-05-28 2000-10-17 Transgene S.A. Defective adenoviruses and corresponding complementation lines
US6120764A (en) 1993-06-24 2000-09-19 Advec, Inc. Adenoviruses for control of gene expression
US6140087A (en) 1993-06-24 2000-10-31 Advec, Inc. Adenovirus vectors for gene therapy
AU7353494A (en) 1993-11-12 1995-05-29 Case Western Reserve University Episomal expression vector for human gene therapy
US5731172A (en) 1994-03-09 1998-03-24 Sumitomo Pharmaceuticals Company, Ltd. Recombinant adenovirus and process for producing the same
US5833993A (en) 1994-04-29 1998-11-10 Pharmacia & Upjohn Company Feline immunodeficiency virus vaccine
US5604090A (en) 1994-06-06 1997-02-18 Fred Hutchinson Cancer Research Center Method for increasing transduction of cells by adeno-associated virus vectors
US5662897A (en) 1994-07-27 1997-09-02 U. Of Ga Research Foundation Insect viruses, sequences, insecticidal compositions and methods of use
US5693508A (en) 1994-11-08 1997-12-02 Chang; Lung-Ji Retroviral expression vectors containing MoMLV/CMV-IE/HIV-TAR chimeric long terminal repeats
JP3770333B2 (ja) 1995-03-15 2006-04-26 大日本住友製薬株式会社 組換えdnaウイルスおよびその製造方法
GB9506782D0 (en) 1995-04-01 1995-05-24 British Biotech Pharm Retroviral vectors
CA2226575C (en) 1995-07-27 2011-10-18 Genentech, Inc. Stabile isotonic lyophilized protein formulation
JPH11511326A (ja) 1995-08-30 1999-10-05 ジエンザイム コーポレイション アデノウィルスおよびaavの精製
US6013516A (en) 1995-10-06 2000-01-11 The Salk Institute For Biological Studies Vector and method of use for nucleic acid delivery to non-dividing cells
US6020192A (en) 1996-01-18 2000-02-01 University Of Florida Humanized green fluorescent protein genes and methods
US5874304A (en) 1996-01-18 1999-02-23 University Of Florida Research Foundation, Inc. Humanized green fluorescent protein genes and methods
CA2247091A1 (en) 1996-03-05 1997-09-12 The Regents Of The University Of California Recombinant live feline immunodeficiency virus and proviral dna vaccines
US5952221A (en) 1996-03-06 1999-09-14 Avigen, Inc. Adeno-associated virus vectors comprising a first and second nucleic acid sequence
US5891646A (en) 1997-06-05 1999-04-06 Duke University Methods of assaying receptor activity and constructs useful in such methods
US6156303A (en) 1997-06-11 2000-12-05 University Of Washington Adeno-associated virus (AAV) isolates and AAV vectors derived therefrom
US6143565A (en) 1997-08-22 2000-11-07 The United States Of America As Represented By The Secretary Of Agriculture Stable insect virus-cell expression system
US6893827B1 (en) 2000-02-07 2005-05-17 Applera Corporation Receptor function assay for G-protein coupled receptors and orphan receptors by reporter enzyme mutant complementation
EP1345968A2 (en) 2000-12-28 2003-09-24 Altus Biologics Inc. Crystals of whole antibodies and fragments thereof and methods for making and using them
JPWO2003008446A1 (ja) 2001-07-19 2004-11-11 三菱ウェルファーマ株式会社 後期糖化産物受容体のシグナル伝達に関連するポリペプチド
CN1894581B (zh) 2003-07-09 2012-02-01 生命技术公司 检测蛋白-蛋白相互作用的方法
US7488583B2 (en) 2003-09-25 2009-02-10 Odyssey Thera, Inc. Fragment complementation assays for G-protein-coupled receptors and their signaling pathways
ES2473587T3 (es) 2004-08-03 2014-07-07 Transtech Pharma, Inc. Proteínas de fusión de RAGE y métodos de uso
EP1869464A4 (en) 2005-03-17 2009-12-02 Univ Columbia RAGE-DIAPHANOUS INTERACTION AND CORRESPONDING COMPOSITIONS AND METHODS
JP5295785B2 (ja) 2006-02-20 2013-09-18 エファ・ユニバーシティ・インダストリー・コラボレイション・ファウンデイション 細胞膜透過性ペプチド
MX2008011933A (es) 2006-03-21 2008-12-18 Wyeth Corp Metodos y composiciones para antagonismo de rage.
WO2008055314A1 (en) 2006-11-10 2008-05-15 Dimerix Bioscience Pty Ltd Thyrotropin releasing hormone receptor-orexin receptor hetero-dimers/-oligomers
WO2008154638A2 (en) 2007-06-12 2008-12-18 Board Of Regents, The University Of Texas System Antagonists of the receptor for advanced glycation end-products (rage)
US8101373B2 (en) 2007-10-12 2012-01-24 Discoverx Corporation β-galactosidase donor fragments
WO2012109569A1 (en) 2011-02-11 2012-08-16 The Trustees Of Columbia University In The City Of New York The receptor for advanced glycation endproducts (rage) is a receptor for lysophosphatidic acid (lpa)
WO2012159164A1 (en) 2011-05-23 2012-11-29 Phylogica Limited Method of determining, identifying or isolating cell-penetrating peptides
EP2756005B1 (en) 2011-09-14 2016-03-02 Abeterno Technologies Limited Intracellular cell selection
CA3109871A1 (en) * 2017-08-22 2019-02-28 Monash University Screening assays, modulators and modulation of activation of receptor for advanced glycation end-products (rage)

Similar Documents

Publication Publication Date Title
JP2006149365A5 (cg-RX-API-DMAC7.html)
JP2023518596A5 (cg-RX-API-DMAC7.html)
JP2012082206A5 (cg-RX-API-DMAC7.html)
JP2002502589A5 (cg-RX-API-DMAC7.html)
JP2018538356A5 (cg-RX-API-DMAC7.html)
JP2015527882A5 (cg-RX-API-DMAC7.html)
WO2014081702A4 (en) Synthetic linear apelin mimetics for the treatment of heart failure
JP2016501851A5 (cg-RX-API-DMAC7.html)
JP2002506625A5 (cg-RX-API-DMAC7.html)
JP2020517260A5 (cg-RX-API-DMAC7.html)
JP2023542453A5 (cg-RX-API-DMAC7.html)
FI4034555T3 (fi) Dap10/dap12-fuusiopolypeptidit
JP2026035742A5 (cg-RX-API-DMAC7.html)
RU2010141916A (ru) Растворимый мутант рецептора фактора некроза опухоли
JP2004505640A5 (cg-RX-API-DMAC7.html)
JP2004537284A5 (cg-RX-API-DMAC7.html)
JPWO2023282281A5 (cg-RX-API-DMAC7.html)
JP2001515720A (ja) β−デフェンシン
JP2023501308A5 (cg-RX-API-DMAC7.html)
JP2002539829A5 (cg-RX-API-DMAC7.html)
CA2637295C (en) Fgf2-binding peptides and uses thereof
AU779261B2 (en) Bone stimulating factor
WO1994029332A1 (en) Coiled-coil stem loop templates
WO1992014834A1 (en) Insulin-like growth factor binding protein
JP2002538775A5 (cg-RX-API-DMAC7.html)